Novo Nordisk A/S (NONOF)
OTCMKTS · Delayed Price · Currency is USD
57.30
+0.96 (1.70%)
Jan 7, 2026, 11:41 AM EST
Novo Nordisk Market Cap
Novo Nordisk has a market cap or net worth of $253.02 billion as of January 7, 2026. Its market cap has decreased by -46.32% in one year.
Market Cap
253.02B
Enterprise Value
263.76B
Revenue
49.58B
Ranking
n/a
PE Ratio
15.52
Stock Price
$57.30
Market Cap Chart
Since February 18, 1997, Novo Nordisk's market cap has increased from 7.15B to 253.02B, an increase of 3,440.47%. That is a compound annual growth rate of 13.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 254.60B | 11.85% |
| Dec 30, 2025 | 227.63B | -41.00% |
| Dec 30, 2024 | 385.82B | -16.41% |
| Dec 29, 2023 | 461.55B | 51.61% |
| Dec 30, 2022 | 304.43B | 19.34% |
| Dec 30, 2021 | 255.09B | 56.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.98M |
| Elite Pharmaceuticals | 537.20M |
| Northwest Biotherapeutics | 397.78M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| CytoDyn | 342.98M |
| Silence Therapeutics | 290.49M |